1. Home
  2. MAR vs BMY Comparison

MAR vs BMY Comparison

Compare MAR & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marriott International

MAR

Marriott International

HOLD

Current Price

$368.75

Market Cap

97.7B

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$60.77

Market Cap

113.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAR
BMY
Founded
1927
1887
Country
United States
United States
Employees
N/A
32500
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.7B
113.5B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
MAR
BMY
Price
$368.75
$60.77
Analyst Decision
Buy
Buy
Analyst Count
16
15
Target Price
$359.31
$61.73
AVG Volume (30 Days)
1.5M
11.4M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
0.76%
4.38%
EPS Growth
14.17
N/A
EPS
2.43
N/A
Revenue
$26,186,000,000.00
N/A
Revenue This Year
$304.38
N/A
Revenue Next Year
$5.38
N/A
P/E Ratio
$151.51
$17.26
Revenue Growth
4.33
N/A
52 Week Low
$253.76
$42.52
52 Week High
$410.98
$62.89

Technical Indicators

Market Signals
Indicator
MAR
BMY
Relative Strength Index (RSI) 44.84 60.21
Support Level $362.71 $56.46
Resistance Level $384.12 $61.16
Average True Range (ATR) 7.63 1.49
MACD -0.64 0.36
Stochastic Oscillator 35.21 74.06

Price Performance

Historical Comparison
MAR
BMY

About MAR Marriott International

Marriott operates 1.8 million rooms across roughly 30 brands. At the end of 2025, luxury represented roughly 10% of total rooms, premium was 42%, select service was 46%, and midscale was 2%. Marriott, Courtyard, and Sheraton are the largest brands, while Autograph, Tribute, Moxy, Aloft, and Element are newer lifestyle brands. Managed and franchised represented 99% of total rooms as of Dec. 31, 2025. North America makes up 61% of total rooms. Managed, franchise, and incentive fees represent the vast majority of revenue and profitability for the company.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: